The Insectary at the Jenner Institute
- NDM Strategic
- Contact
- Public Involvement
-
News
- Using management thinking to fight the superbug crisis
- Getting rid of malaria possible, if we try something new, say experts
- Success for NDM project awarded Public Engagement Seed Funding
- Flu vaccine spinout secures a further £20m in funding
- Global health needs demand new approach to drug discovery
- Building international partnerships to tackle disease
- Nepali pilgrims to Gosaikunda video
- China Vice Premier in Oxford for signing of research collaboration
- Largest genetic study of mosquitoes reveals spread of insecticide resistance across Africa
- Researchers attack Mekong malaria superbug on multiple fronts
- Kevin Marsh Wins 2017 Drexel Prize in Infectious Disease
- Prof Simon Leedham wins CRUK Prize
- Oxford-Mahidol collaboration shortlisted for Newton Prize
- Study raises possibility of vaccines against allergies and Alzheimer’s
- Celebrating Oxfordshire brightest science stars
- New structural insights accelerate drug discovery in the ubiquitin system for cancer therapy
- National Academy of Medicine elects Nick White as international member
- New collaboration to tackle superbugs
- 115 years of malaria in Africa
- Oxford and the mosquito
- World-first trial for universal flu vaccine
- New typhoid vaccine offers hope of protection for children
- Prof Emily Chan wins the 2017 UGC Teaching Award
- The Medical Research Foundation to fund first national PhD Training Programme to tackle antimicrobial resistance
- Superbug’s spread to Vietnam threatens malaria control
- Establishing the Africa Oxford Initiative
- Experts urge rethink of ‘outdated’ asthma categorisation
- International research network nominated for ‘Oscar of higher education’
- Oxford University claims top world ranking for second year
- Bash the Bug! Winner of 2017 NIHR Let’s Get Digital competition
- Scientists discover unknown virus in ‘throwaway’ DNA
- Improved home designs may fight malaria in Africa
- Antibodies may reveal timing of previous influenza infection
- Is it time to drop the ‘complete the course’ message for antibiotics?
- Quick test can predict anaemia in malaria patients treated with artemisinins
- Cancer hijacks natural cell process to survive
- Mahidol begins Asia’s first study of RTS,S malaria vaccine
- Oxford one of six sites to receive funding for health data science
- Five surprising things DNA has revealed about our ancestors
- OUMNH Exhibition based on centre research
- Could aspirin be used to treat tuberculous meningitis?
- ALS Reproducible Antibody Platform launched
- Cultural barriers to tackling the superbug crisis
- ALERRT epidemic research network launched in sub-Saharan Africa
- Making malaria visible
- Women in STM
- Female body shape gene may increase risk of type 2 diabetes
- The town that breeds resistance to Malaria drugs
- Can you cure HIV?
- Professor Dominic Kwiatkowski joins the Fellowship of the Royal Society
- Prof Vincenzo Cerundolo elected Fellow of the Royal Society
- NDM Researchers elected as Fellows of the Academy of Medical Science
- Using management thinking to fight the superbug crisis
- FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration
- HIV researchers create Chelsea garden to raise awareness of disease stigma
- China Vice Premier and Minster of National Health Commission visit to CTI Beijing
- Oxford overtakes Cambridge for first time in QS world rankings
- New age-based regimen for single low-dose primaquine to block malaria transmission
- Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies
- Big Data Institute wins a 2018 RIBA South Award
- NDM Researcher gets £1m boost to study immunology of asthma
- Professor Rose McGready awarded Alumni Award for Service to Humanity
- Researchers explore malaria vaccines and antibiotic resistance at RS Summer Science Exhibition
- Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved
- NDM Researcher recognised for major contribution in clinical sciences
- ASHG Honours Professor Cecilia Lindgren with Mentorship Award
- New NDM Professors
- Prof Helen McShane appointed as new Director of Oxford Biomedical Research Centre
- Detailed map of colon cells in health and disease
- UK-led study marks shift towards genetic era in tackling TB
- Tales of treatment, of modernity and tradition, and of global health crisis
- Faith Osier TED talk
- 'Tantalising and exciting’: UK Biobank genetics opens the door to a new era of health research
- Oxford secures £17.5 million to lead national programmes in AI to improve healthcare
- New grant to study the role of immune cells in lung regeneration
- Dr Ross Chapman welcomed as EMBO Young Investigator
- New vaccines centre to protect UK from pandemic threats
- Professor Sir David Weatherall: 1933-2018
- Congratulations to Jeremy Farrar, knighted in the New Year's Honours 2019
- Watch Prof Peter Donnelly speak at Royal Society AI event
- NDM's Translational Gastroenterology Unit awarded a CRUK Primer grant of £100,000
- ISARIC awarded £4.5 million to tackle the global threat of epidemic infectious diseases
- Tracking resistance results presented at Westminster
- The battle within- new animation on the immune system
- Vaccine developed to treat osteoarthritic pain
- World Malaria Day 2019
- Faces of malaria
- Mads Gyrd-Hansen awarded Wellcome Trust Senior Research Fellowship renewal
- NDM Researchers elected Fellows of the Academy of Medical Sciences
- Oxford academics recognised in 2019 Queen’s Birthday Honours
- Ross Chapman awarded 2019 Lister Prize
- New maps could show how to beat malaria
- Vice-Chancellor’s Choice Award for Public Engagement with Research
- New malaria parasite mutations cause alarming antimalarial drug failures in Southeast Asia
- New NDM Professors
- Woman of the Future award for Science
- Medical Sciences and climate breakdown: time to move beyond evidence
- Oxford Tropical Medicine awarded two RSTMH medals
- Landmark partnership announced for development of COVID-19 vaccine
- Chan Zuckerberg Initiative awards funding to Oxford team to support inflammation research
- Oxford University Coronavirus Research Webinar
- New study reveals Oxford coronavirus vaccine produces strong immune response
- The Duke of Cambridge visits Oxford Vaccine Centre
- The Ludwig Institute for Cancer Research welcomes cancer epigenetics researcher Yang Shi
- New NDM titles awarded
- Future of Oxford professorship in vaccinology secured with £3.5 million gift
- Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme
- Dave Stuart awarded The Gabor Medal 2020
- Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
- Collaboration with Magdalen College outreach to run remote work experience
- Persistent immune memory of COVID-19 found in recovered patient T cells
- New research shows tracing apps can save lives at all levels of uptake
- Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
- Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
- Professor Sarah Walker, a Professor of Medical Statistics and Epidemiology in NDM and the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE.
- Simon Leedham appointed as Professor of Molecular and Population Genetics
- Two vital research programmes taking place at the university of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients.
- New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
- NDM’s Jenner Institute appoints first Bvlgari Scholars
- NDM New Professors
- Trials of Oxford coronavirus vaccine begin in Kenya
- Oxford ramps up COVID-19 testing capability
- Oxford’s vaccine research and development boosted by donation from Wafic Saïd
- Oxfordshire Young Scientists of the Year 2020
- Oxford University breakthrough on global COVID-19 vaccine
- First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
- Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020
- National COVID-19 Infections Survey reveals changes to pandemic over time
- Professor Susie Dunachie awarded flagship NIHR career development award
- Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
- Professor Sir Dave Stuart, FRS FMedSci knighted in New Year's Honours
- National consortium to study threats of new SARS-CoV-2 variants
- Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of the current lockdown
- Oxford Cancer Centre appoints Professor Tim Elliot as new co-director
- Infectious disease experts estimate that using the NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections
- Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests
- Tocilizumab reduces deaths in patients hospitalised with COVID-19
- World’s largest clinical trial for COVID-19 treatments expands internationally
- Graduate access programmes now open for 2021 applications
- Professor Sarah Gilbert awarded RSA Albert Medal
- Professor Cecilia Lindgren appointed Director of the Big Data Institute
- USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
- The RECOVERY Trial: One year on
- Oxford University researchers release cheap, quick COVID-19 antibody test
- CCOUC Webinar on Health-EDRM Education and Research in China: Commemorating the 512 Wenchuan Earthquake
- National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines
- Director of NDM's Jenner Institute elected to The Royal Society
- Five new Academy of Medical Sciences Fellows from NDM
- Oxford University and Oracle partner to speed identification of COVID-19 variants
- RECOVERY trial named David Sackett Trial of the Year 2020
- University of Oxford to launch Pandemic Sciences Centre
- NDM Researchers recognised in Queen’s Birthday Honours
- RECOVERY Trial identifies another effective COVID-19 treatment
- Daily contact COVID-19 testing for students effective at controlling transmission in schools
- African trial of novel HIV vaccine candidate starts
- NDM New Associate Professors
- New NDM Professors
- Information Governance
The Jenner Institute was founded in November 2005 in partnership with the Institute for Animal Health. Our Institute focuses both on diseases of humans and livestock. One of the founding principles of the Institute is the exploitation of synergies in the development of human and veterinary vaccines whereby new vaccine approaches can be tested in parallel in different species.
Podcast created by NDM for The Insectary at the Jenner Institute
The Jenner Institute Insectary at the Old Road Campus Research Building is used for the rearing of mosquitoes. Researchers then use these mosquitoes to test vaccines against malaria, a disease caused by Plasmodium parasites that are transmitted from one person to another by female Anopheles mosquitoes. Our colony of Anopheles stephensi mosquitoes are reared in state-of –the-art temperature and humidity controlled incubators. The female mosquito lays her eggs in water, where they hatch after a few days. These aquatic larvae feed and develop through four stages, or instars, before pupation and emergence into adulthood. It takes two weeks after hatching for the mosquitoes to become adults.
The mosquitoes are used to produce sporozoites, which grow inside the mosquito salivary gland and are infective to the vertebrate host. We use sporozoites to test vaccines targeting the liver and blood stages of malaria infection. If the vaccine is protective then we see reduced parasites in the blood in comparison to the unvaccinated controls.
The facility is also used to test transmission-blocking malaria vaccines that aim to halt the sexual development of the malaria parasite in the mosquito. For this we grow the male and female forms of the human malaria parasite in red blood cells, mix them with antibodies induced through vaccination, and feed the mixture to the mosquitoes using an artificial membrane feeder. In the mosquito midgut the male and female parasites join and fertilise to form a zygote which then develops into an oocyst. The mosquitoes are kept in highly secure cabinets for a week before they are dissected and checked for the development of parasites in the midgut. If the vaccine works then we don't see any sporozoite producing oocysts in the midgut.
If you are interested in our research, you can look at the Jenner Institute website and contact us.
Malaria Vaccines
Malaria kills around 0.8 million individuals per annum, mostly in sub-Saharan Africa where 1 in 5 childhood deaths is associated with malaria. The disease is spread from one individual to another by the bite of a female Anopheles mosquito. Developing a vaccine against malaria has been difficult due to the ever changing nature of the parasite in terms of its genetic diversity and life-cycle (pre-erythrocytic stage, blood-stage and mosquito-stage). Malaria vaccine development at the Jenner Institute is divided into three main areas:
The programme of pre-clinical malaria vaccine development at Oxford has led to significant advances in the field of vectored vaccines. This work began with a primary interest in the induction of high level T cell responses against pre-erythrocytic liver-stage malaria antigens. This has now widened to also include high level antibody induction against the blood-stage and mosquito-stage using both viral vectored and protein-in-adjuvant vaccines.